Global Veterinary Products for Companion Animals Market Outlook, 2030

The Global Veterinary Products for Companion Animals Market is a thriving sector, driven by the increasing humanization of pets and the growing awareness of animal health and wellness. As pets are increasingly considered family members, owners are investing heavily in their care, leading to a surge in demand for veterinary products such as pharmaceuticals, vaccines, diagnostics, and feed additives. This market is further fueled by the rising prevalence of chronic diseases in pets, including diabetes, arthritis, and cancer, which necessitate advanced medical interventions. Technological advancements, such as telemedicine, wearable health monitoring devices, and innovative diagnostic tools, are revolutionizing veterinary care, enabling timely and accurate detection of health issues. Governments and regulatory bodies are also playing a pivotal role by streamlining approval processes for new veterinary drugs and vaccines, fostering innovation and accessibility. Pet ownership continues to rise globally, coupled with increasing disposable incomes and awareness of preventive healthcare, the Global Veterinary Products for Companion Animals Market is poised for sustained expansion, offering innovative solutions to enhance the quality of life for pets and their owners.

The global Veterinary Products for Companion Animals market size is predicted to grow from US$ 16960 million in 2025 to US$ 23940 million in 2031; it is expected to grow at a CAGR of 5.9% from 2025 to 2031. The Global Veterinary Products for Companion Animals Market is characterized by dynamic trends and robust drivers that are reshaping the industry. A notable trend is the increasing adoption of wearable electronics for preventive pet healthcare, enabling real-time monitoring and early detection of health issues. The market is also witnessing a surge in demand for personalized pet care products, driven by advancements in veterinary diagnostics and pharmaceuticals. Key drivers include the rising prevalence of chronic and infectious diseases among pets, growing pet ownership rates, and heightened awareness of preventive healthcare measures. Governments worldwide are implementing trade programs and policies to support the development and adoption of advanced veterinary products. For instance, subsidies for veterinary research and development, along with incentives for adopting innovative technologies, are fostering market growth. Additionally, collaborations between veterinary pharmaceutical companies and research institutions are accelerating the development of novel therapeutics and diagnostics tailored for companion animals. The market continues to evolve, these trends and drivers are shaping a future where veterinary care is more efficient, accessible, and tailored to the unique needs of pets and their owners.

The medicines category encompasses a comprehensive range of therapeutic products including antibiotics for bacterial infections, antiparasitics for flea/tick/worm control, NSAIDs for pain management, and specialized medications for chronic conditions like diabetes and arthritis, along with emerging demand for personalized compounded formulations to meet individual pet needs. In parallel, the veterinary vaccines segment focuses on disease prevention through core vaccines (rabies, distemper, parvovirus) and lifestyle-based immunizations (Lyme disease, feline leukemia), with technological advancements enabling safer recombinant and adjuvant-enhanced formulations. While medicines dominate market revenue due to increasing age-related disorders and parasitic infestations in pets, vaccines are witnessing accelerated growth driven by rising pet adoption rates, zoonotic disease awareness, and mandatory vaccination policies. Both segments benefit from key industry trends including biopharmaceutical innovations, the integration of telemedicine in veterinary care, and expanding pet insurance coverage, though they serve fundamentally different purposes - vaccines as proactive health safeguards and medicines as reactive treatment solutions. The market landscape is further shaped by stringent regulatory frameworks for drug approvals, growing preference for online pet pharmacies, and heightened consumer awareness about preventive healthcare, with developed markets emphasizing premium vaccine protocols while emerging economies show stronger growth in essential medicines.

Dogs represent the largest share due to high global ownership rates, with approximately 68 million households in the U.S. alone owning at least one dog. Veterinary products for dogs include vaccines, parasiticides, anti-infectives, and medications for chronic diseases such as arthritis and diabetes, while preventive care solutions like flea and tick control, heartworm preventatives, and nutritional supplements drive additional market growth. The aging dog population and increased human-animal bonding further fuel the demand for advanced treatments and diagnostics, supported by pet insurance availability. The cat segment, which represents the second-largest market, is experiencing accelerated growth with an increasing number of urban households adopting cats, currently 49 million in the U.S. The feline veterinary market includes vaccines for feline leukemia and respiratory illnesses, parasiticides, antibiotics, and treatments for kidney disease and hyperthyroidism, with preventive care and nutritional supplements gaining traction. Manufacturers focus on palatable and easy-to-administer medications, catering to the growing humanization of cats. The others segment includes rabbits, birds, small mammals, and reptiles, with veterinary products designed for species-specific health concerns, such as dental problems in rabbits, parasitic infections in small mammals, and reptile-specific formulations. The growing popularity of exotic pets, advancements in specialized veterinary care, and availability of online health resources continue to drive market expansion across all segments, reinforcing the demand for customized veterinary solutions and enhanced healthcare options for companion animals.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030



Aspects covered in this report
• Veterinary Products for Companion Animals Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Segmentation by Type:
• Medicines
• Veterinary Vaccines
Segmentation by Application:
• Dogs
• Cats
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to agriculture industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.